A Multicentre, Double-Blind, Randomised, Parallel-Group, Phase II Study to Assess Efficacy and Safety of D9421-C 9 mg and 15 mg Versus Placebo in Japanese Patients With Active Crohn's Disease
Latest Information Update: 03 Oct 2021
At a glance
- Drugs Budesonide (Primary)
- Indications Crohn's disease
- Focus Therapeutic Use
- Sponsors AstraZeneca
- 25 Jan 2012 New trial record